2024 Hot-pe trial

Hot-pe trial

Author: fwcg

August undefined, 2024

WebOct 23, 2024 · What does HOME-PE teach us, also viewed against the background of existing data and particularly those of the recent Home Treatment of Pulmonary Embolism (HoT-PE) 7, 10 trial? Both studies, the main characteristics of which are shown for comparison in Table 1 , yielded excellent results in terms of efficacy and safety of an … WebPulmonary embolism is a common disease, with an estimated annual incidence of 70 cases per 100,000 population. 1,2 The condition usually leads to hospitalization and may recur; it can be fatal. 3 ...

Trial clarifies which patients with acute pulmonary embolism …

WebMay 4, 2024 · Embolism (HoT-PE) Trial Running head: Home treatment of low-risk PE in fragile patients Lukas Hobohm, MD1,2, Toni Anušić3, Stavros V Konstantinides, MD1,4, … WebMay 23, 2024 · The HoT-PE Trial was a prospective multicentre single-arm investigator-initiated Phase 4 interventional trial, in which patients with symptomatic acute PE were … linens and things clarksville tn

Home treatment of patients with low-risk pulmonary embolism …

WebThe HoT- PE. X PE. Pulmonary embolism (= PE). A potentially fatal condition caused by a blood clot blocking a vessel in the lung: usually the clot originates from a DVT in the legs. … WebThe HoT-PE Trial 3 Male, 81 ≥ 1 Major bleedinga 20 mg once daily 57 12 Haemorrhagic shock following acute bleeding from intestinal diverticula. Red blood cell concentrates; rivaroxaban discontinuation and switch to LMWH. Subsequently, the patient suffered one further gastrointestinal major bleeding episode on heparin. WebSep 18, 2024 · The Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban (HoT-PE) ... TABLE 2: Early discharge … linens and things macon ga

Early Discharge and Ambulatory Treatment of Selected …

Diagnosis, Treatment and Follow Up of Acute Pulmonary …

WebMar 20, 2024 · HoT-PE 4. Trial design: A prospective, multicenter, single-arm, investigator-initiated, and academically sponsored management trial to investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE (identified through a modified Hestia criteria) in patients taking XARELTO ® (15 mg twice … WebMay 4, 2024 · Embolism (HoT-PE) Trial Running head: Home treatment of low-risk PE in fragile patients Lukas Hobohm, MD1,2, Toni Anušić3, Stavros V Konstantinides, MD1,4, Stefano Barco, MD1,5 for the HoT-PE Investigators 1Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University, … linens and things couponWebThe HoT-PE Trial 3 Male, 81 ≥ 1 Major bleedinga 20 mg once daily 57 12 Haemorrhagic shock following acute bleeding from intestinal diverticula. Red blood cell concentrates; … linens and things ma

"WebSep 27, 2016 · Erratum to Barco et al. "Home treatment of patients with lowrisk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the Hot … " - Hot-pe trial

Hot-pe trial

Ambulatory Treatment of Low-risk Pulmonary Embolism in Fragile …

WebStudy design and participants. HoT-PE (EudraCT identifier 2013-001657-28) is a prospective multicentre single-arm investigator-initiated phase 4 interventional trial sponsored by the University Medical Center Mainz, Mainz, Germany [].The institutional Ethics Review Board of each participating site approved the study and patients provided … WebMar 15, 2024 · • In patients with acute low-risk PE (including absence of RV dysfunction and intracardiac thrombi), early discharge and home treatment with rivaroxaban was feasible, …

Did you know?

WebNov 25, 2024 · Subgroup analyses of randomized trials and cohort studies on direct oral anticoagulants (DOACs) suggested that single direct drug treatment may be effective … WebMar 24, 2016 · The HoT-PE Trial (home treatment of patients with low-risk PE with the oral factor Xa inhibitor rivaroxaban) is a prospective cohort study enrolling low risk PE patients (defined by the absence of ...

WebJan 21, 2024 · Aims: To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE, using the oral factor Xa inhibitor rivaroxaban. …

WebRationale and design of the Hot-PE Trial” (Thromb Haemost 2016; 116: 191-197) Stefano Barco. 1 Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University, Mainz, Germany, Mareike Lankeit. 1 ... WebOct 8, 2024 · Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT …

WebAcross trials, 24%–46% of patients with index PE had anatomically extensive PE, 39–41 and 28% of patients with index PE had RVD. 41 Available data in these subgroups, although scarce, suggest that the effect in patients with index PE is consistent regardless of anatomical extension of PE, 34 or presence/absence of RVD. 41

WebMar 16, 2024 · Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban: the HoT-PE Study Posted: 03/16/2024; Author: … hotte philips whirlpoolWebMar 16, 2024 · Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban: the HoT-PE Study Posted: 03/16/2024; Author: Stavros Konstantinides, MD; ACC Slide Presentations 2024; linens and lingerie boca ratonWebAug 31, 2024 · Patients with acute pulmonary embolism can be selected for home management using the sPESI score or the Hestia criteria, according to results of the HOME-PE trial presented in a Hot Line session ... hotte pharmacieWebAug 31, 2024 · Sophia Antipolis, France – 31 Aug 2024: Patients with acute pulmonary embolism can be selected for home management using the sPESI score or the Hestia criteria, according to results of the HOME-PE trial presented in a Hot Line session today at ESC Congress 2024. 1. Principal investigator Professor Pierre-Marie Roy of the … hotte plafond encastrable extra plateWebMar 20, 2024 · Barco S, Schmidtmann I, Ageno W, et al; on behalf of the HoT-PE Investigators. Early discharge and home treatment of patients with low-risk pulmonary … hotte plafond aegWebHome treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban : Rationale and design of the HoT-PE Trial. / Barco, Stefano; Lankeit, Mareike; Binder, Harald et al. In: THROMBOSIS AND HAEMOSTASIS, Vol. 116, No. 1, 01.07.2016, p. 191-197. Research output: Contribution to journal › Article › peer-review linens and things fredericksburg txWebFeb 4, 2024 · Introduction: Early discharge of patients with acute low-risk pulmonary embolism requires validation by prospective trials with clinical and quality-of-life … hotte phyto